Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 18 | 2023 | 775 | 6.360 |
Why?
|
| Bacterial Translocation | 7 | 2019 | 27 | 3.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2023 | 226 | 3.090 |
Why?
|
| Lipopolysaccharides | 6 | 2022 | 455 | 2.500 |
Why?
|
| Influenza Vaccines | 4 | 2019 | 56 | 2.330 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2022 | 756 | 2.240 |
Why?
|
| Microbiota | 4 | 2022 | 79 | 2.230 |
Why?
|
| HIV-1 | 7 | 2021 | 177 | 1.950 |
Why?
|
| B-Lymphocytes | 5 | 2016 | 329 | 1.880 |
Why?
|
| Interferon Type I | 3 | 2022 | 32 | 1.810 |
Why?
|
| Autoantibodies | 8 | 2023 | 434 | 1.660 |
Why?
|
| Immunoglobulin G | 5 | 2023 | 481 | 1.530 |
Why?
|
| Lymphocyte Activation | 4 | 2019 | 397 | 1.530 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 110 | 1.490 |
Why?
|
| Influenza, Human | 4 | 2019 | 79 | 1.450 |
Why?
|
| CD4 Antigens | 2 | 2022 | 42 | 1.420 |
Why?
|
| Immunologic Memory | 4 | 2016 | 75 | 1.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2022 | 73 | 1.190 |
Why?
|
| CD4 Lymphocyte Count | 8 | 2023 | 98 | 1.160 |
Why?
|
| Macrophages | 2 | 2021 | 647 | 1.050 |
Why?
|
| Bacteria | 3 | 2022 | 193 | 1.010 |
Why?
|
| DNA, Ribosomal | 3 | 2021 | 59 | 0.980 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2021 | 85 | 0.950 |
Why?
|
| DNA, Bacterial | 3 | 2021 | 150 | 0.950 |
Why?
|
| Inflammation | 2 | 2021 | 1030 | 0.880 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 186 | 0.880 |
Why?
|
| Coronavirus 229E, Human | 1 | 2022 | 2 | 0.860 |
Why?
|
| Antibodies, Antinuclear | 2 | 2022 | 171 | 0.850 |
Why?
|
| Anti-Retroviral Agents | 3 | 2019 | 53 | 0.850 |
Why?
|
| Immune Reconstitution | 1 | 2022 | 4 | 0.840 |
Why?
|
| Apoptosis | 4 | 2017 | 1641 | 0.830 |
Why?
|
| Monocytes | 4 | 2016 | 210 | 0.820 |
Why?
|
| Cryptococcus | 1 | 2022 | 7 | 0.820 |
Why?
|
| Humans | 35 | 2023 | 68549 | 0.810 |
Why?
|
| Autoantigens | 1 | 2022 | 91 | 0.780 |
Why?
|
| Staphylococcus aureus | 1 | 2022 | 175 | 0.770 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.750 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 99 | 0.740 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.730 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 191 | 0.720 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 121 | 0.720 |
Why?
|
| Vaccination | 2 | 2022 | 182 | 0.700 |
Why?
|
| Killer Cells, Natural | 2 | 2017 | 94 | 0.700 |
Why?
|
| Antibodies, Neutralizing | 2 | 2016 | 46 | 0.700 |
Why?
|
| Anti-HIV Agents | 2 | 2018 | 135 | 0.670 |
Why?
|
| Antibody Affinity | 1 | 2019 | 26 | 0.670 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.660 |
Why?
|
| Immunity, Humoral | 2 | 2015 | 42 | 0.640 |
Why?
|
| Membrane Cofactor Protein | 1 | 2017 | 7 | 0.620 |
Why?
|
| HIV Antibodies | 1 | 2018 | 28 | 0.620 |
Why?
|
| Estrogen Receptor beta | 1 | 2017 | 19 | 0.600 |
Why?
|
| Pregnancy Trimester, First | 1 | 2017 | 43 | 0.600 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 25 | 0.600 |
Why?
|
| Female | 18 | 2022 | 38021 | 0.600 |
Why?
|
| Family | 1 | 2019 | 293 | 0.590 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 209 | 0.590 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 101 | 0.590 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 92 | 0.580 |
Why?
|
| Case-Control Studies | 5 | 2021 | 1549 | 0.580 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 65 | 0.570 |
Why?
|
| Estradiol | 1 | 2017 | 176 | 0.550 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 56 | 0.550 |
Why?
|
| Premature Birth | 1 | 2018 | 150 | 0.540 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 778 | 0.520 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 219 | 0.520 |
Why?
|
| Streptococcus pneumoniae | 1 | 2015 | 32 | 0.510 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 30 | 0.500 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 626 | 0.500 |
Why?
|
| Middle Aged | 12 | 2022 | 21119 | 0.490 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 286 | 0.490 |
Why?
|
| Autophagy | 2 | 2013 | 208 | 0.490 |
Why?
|
| Adult | 12 | 2022 | 21379 | 0.480 |
Why?
|
| Depressive Disorder | 1 | 2017 | 621 | 0.460 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 126 | 0.450 |
Why?
|
| Male | 14 | 2022 | 37283 | 0.440 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2014 | 135 | 0.440 |
Why?
|
| Ceramides | 2 | 2013 | 578 | 0.430 |
Why?
|
| Sex Characteristics | 1 | 2014 | 295 | 0.420 |
Why?
|
| Brain | 1 | 2021 | 2176 | 0.380 |
Why?
|
| Biomarkers | 3 | 2022 | 1593 | 0.350 |
Why?
|
| Sex Factors | 3 | 2019 | 1265 | 0.350 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1293 | 0.340 |
Why?
|
| Mice | 5 | 2022 | 8474 | 0.340 |
Why?
|
| Animals | 10 | 2022 | 20880 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2014 | 2689 | 0.320 |
Why?
|
| DNA | 2 | 2022 | 597 | 0.310 |
Why?
|
| Cell Line | 2 | 2022 | 1752 | 0.300 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2016 | 13 | 0.280 |
Why?
|
| ADP-ribosyl Cyclase 1 | 2 | 2017 | 24 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 2791 | 0.260 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2015 | 23 | 0.250 |
Why?
|
| Interleukin-6 | 2 | 2017 | 330 | 0.240 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 370 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 2550 | 0.220 |
Why?
|
| Patient Acuity | 1 | 2022 | 17 | 0.220 |
Why?
|
| Peptidoglycan | 1 | 2022 | 14 | 0.210 |
Why?
|
| Cell Wall | 1 | 2022 | 21 | 0.210 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 20 | 0.210 |
Why?
|
| Lipid A | 1 | 2022 | 9 | 0.210 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.210 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2022 | 4 | 0.210 |
Why?
|
| Young Adult | 3 | 2019 | 5710 | 0.210 |
Why?
|
| Neurofilament Proteins | 1 | 2022 | 20 | 0.210 |
Why?
|
| Pregnancy | 2 | 2018 | 2334 | 0.200 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 89 | 0.200 |
Why?
|
| Healthy Volunteers | 1 | 2022 | 78 | 0.200 |
Why?
|
| Feces | 1 | 2022 | 88 | 0.200 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 172 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2673 | 0.200 |
Why?
|
| Cyclic AMP | 1 | 2022 | 223 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2022 | 107 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 138 | 0.190 |
Why?
|
| Permeability | 1 | 2021 | 131 | 0.190 |
Why?
|
| Protein Isoforms | 1 | 2022 | 246 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.190 |
Why?
|
| Phylogeny | 1 | 2021 | 196 | 0.190 |
Why?
|
| Cytokines | 2 | 2022 | 866 | 0.170 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 799 | 0.170 |
Why?
|
| Germinal Center | 1 | 2019 | 13 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 444 | 0.170 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.170 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1663 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2019 | 156 | 0.160 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 17 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 66 | 0.150 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 37 | 0.150 |
Why?
|
| Keratins | 1 | 2017 | 48 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2022 | 753 | 0.150 |
Why?
|
| Progesterone | 1 | 2018 | 115 | 0.150 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2017 | 8 | 0.150 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 7 | 0.150 |
Why?
|
| B7-1 Antigen | 1 | 2016 | 20 | 0.140 |
Why?
|
| CD40 Ligand | 1 | 2016 | 14 | 0.140 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 19 | 0.140 |
Why?
|
| Risk | 1 | 2018 | 563 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.140 |
Why?
|
| Seasons | 1 | 2016 | 129 | 0.140 |
Why?
|
| Ki-67 Antigen | 1 | 2016 | 28 | 0.140 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2015 | 5 | 0.140 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2015 | 10 | 0.140 |
Why?
|
| Neutralization Tests | 1 | 2015 | 19 | 0.140 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 30 | 0.130 |
Why?
|
| Protein Binding | 2 | 2017 | 1027 | 0.130 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 80 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2265 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2017 | 432 | 0.130 |
Why?
|
| Vaccines | 1 | 2015 | 21 | 0.130 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 30 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.120 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2014 | 8 | 0.120 |
Why?
|
| Immunoglobulin D | 1 | 2014 | 14 | 0.120 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 64 | 0.120 |
Why?
|
| fas Receptor | 1 | 2014 | 54 | 0.120 |
Why?
|
| Gene Expression | 1 | 2016 | 770 | 0.120 |
Why?
|
| Cell Separation | 1 | 2014 | 132 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 69 | 0.120 |
Why?
|
| Aged | 2 | 2022 | 14842 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2014 | 110 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1582 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2014 | 489 | 0.110 |
Why?
|
| Cell Survival | 2 | 2015 | 901 | 0.110 |
Why?
|
| Phagosomes | 1 | 2012 | 19 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2014 | 201 | 0.110 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 2002 | 69 | 0.100 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.100 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2011 | 62 | 0.100 |
Why?
|
| Child | 1 | 2019 | 6401 | 0.080 |
Why?
|
| Heart | 2 | 2002 | 850 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 756 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2011 | 617 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 250 | 0.070 |
Why?
|
| Adolescent | 1 | 2019 | 8904 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2011 | 447 | 0.070 |
Why?
|
| United States | 1 | 2018 | 7338 | 0.070 |
Why?
|
| Integrins | 2 | 2002 | 115 | 0.060 |
Why?
|
| Neoplasms | 1 | 2011 | 1664 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2000 | 62 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2000 | 213 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 214 | 0.040 |
Why?
|
| Selegiline | 1 | 1997 | 3 | 0.040 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1997 | 30 | 0.040 |
Why?
|
| Cats | 3 | 2002 | 292 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 1851 | 0.040 |
Why?
|
| Stem Cells | 1 | 1997 | 248 | 0.030 |
Why?
|
| Retina | 1 | 1997 | 252 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 127 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 317 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 312 | 0.030 |
Why?
|
| Muscle Cells | 2 | 2002 | 30 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 1037 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 56 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 337 | 0.030 |
Why?
|
| Cell Death | 1 | 2012 | 329 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2011 | 93 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 298 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 194 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1174 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 16 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2002 | 32 | 0.010 |
Why?
|
| Exons | 1 | 2002 | 122 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 140 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 247 | 0.010 |
Why?
|
| Vitronectin | 1 | 2000 | 12 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2000 | 27 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 1015 | 0.010 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2000 | 26 | 0.010 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2000 | 26 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2000 | 35 | 0.010 |
Why?
|
| Laminin | 1 | 2000 | 62 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 614 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2000 | 84 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 130 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 150 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 147 | 0.010 |
Why?
|
| Tyrosine | 1 | 2000 | 196 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 195 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 1033 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 249 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 791 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 954 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 85 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 1200 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 455 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 636 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 351 | 0.010 |
Why?
|
| Cell Count | 1 | 1997 | 248 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2000 | 493 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 473 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 1040 | 0.010 |
Why?
|
| Myocardium | 1 | 2000 | 1204 | 0.010 |
Why?
|
| Time Factors | 1 | 2000 | 4655 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 5300 | 0.010 |
Why?
|